SCHEMBL25651237

SCHEMBL25651237

O=C(N[C@H](C(=O)Oc1c(F)c(F)c(F)c(F)c1F)C(C1CC1)C1CC1)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 4/20 0.45
CTSL P07711 3/20 0.45
CCR1 P32246 1/20 0.44
CTSK P43235 3/20 0.43
CTSB P07858 3/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
POLB P06746 1/20 0.43
CYP2D6 P10635 1/20 0.43
TSHR P16473 1/20 0.43
CASP1 P29466 1/20 0.43
CASP3 P42574 1/20 0.43
CASP7 P55210 1/20 0.43
CASP6 P55212 1/20 0.43
CASP8 Q14790 1/20 0.43
ATM Q13315 1/20 0.43
CTRB1 P17538 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25651236 1.00 CTSS (0.45) CTSSCTSLCCR1CTSKCTSB
SCHEMBL24103310 0.86 TRPM8 (0.56) CTSSCTSLCCR1CTSKCTSB
SCHEMBL25649913 0.86 TRPM8 (0.56) CTSSCTSLCCR1CTSKCTSB
SCHEMBL24103515 0.86 TRPM8 (0.56) CTSSCTSLCCR1CTSKCTSB
SCHEMBL30656002 0.84 CTSB (0.55) CTSSCTSLCTSKCTSBCASP1
SCHEMBL24103811 0.83 ALDH1A1 (0.50) CTSSCTSLCCR1CTSKCTSB
SCHEMBL24103513 0.83 ALDH1A1 (0.50) CTSSCTSLCCR1CTSKCTSB
SCHEMBL25275405 0.83 ALDH1A1 (0.50) CTSSCTSLCCR1CTSKCTSB
SCHEMBL29028055 0.80 TRPM8 (0.53) CTSSCTSLCTSKCTSBCYP2C9
SCHEMBL30419679 0.80 TRPM8 (0.53) CTSSCTSLCTSKCTSBCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250197378-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA AS (DK) 2025-06-19 US disclosed
EP-4486737-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO Pharma A/S (DK) 2025-01-08 EP disclosed
US-12065429-B2 Small molecule modulators of IL-17 LEO PHARMA A/S (DK) 2024-08-20 US disclosed
US-20240208938-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2024-06-27 US disclosed
WO-2024115662-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2024-06-06 WO disclosed
WO-2023166172-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2023-09-07 WO disclosed
WO-2023166172-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2023-09-07 WO disclosed
WO-2023111181-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2023-06-22 WO disclosed
WO-2023111181-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2023-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250197378-A1 SMALL MOLECULE MODULATORS OF IL-17 IL17A, IL2, IL23R CTSS 583/4885CTSL 555/4885CCR1 739/4885
US-20240208938-A1 SMALL MOLECULE MODULATORS OF IL-17 IL17A, IL23R, IL15 CTSS 680/4885CTSL 909/4885CCR1 398/4885
US-12065429-B2 Small molecule modulators of IL-17 IL17A, IL23R, IL15 CTSS 680/4885CTSL 909/4885CCR1 398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.